Table 1.
Previous reports concerning survival outcomes by each macroscopic type
| First author/Ref | Year | Macroscopic type | n (%) | 5‐y OS rate (%) | P value |
|---|---|---|---|---|---|
| Yamashita3 | 2017 | Others/giant III or IV | 154 (90)/18 (10) | 76.6/34.0 | <0.0001 |
| Huang15 | 2016 | Others/IV | 1487 (92)/135 (8) | 45.3/19.7 | <0.0001 |
| Yamashita14 | 2015 | IV | 287 | 16.0 | NA |
| Yamashita13 | 2014 | I or II or V/III/IV | 80 (34)/106 (46)/46 (20) | 50a/20a/5a | <0.0001 |
| Noda37 | 2011 | Others/IV | 1300 (88)/174 (12) | 27.7/6.3 | 0.023 |
| Li16 | 2009 | I or II/III/IV | 1115 (28)/2334 (59)/517 (13) | 67.7/55.2/31.8 | <0.001 |
| Msika38 | 2000 | I/II/III/IV/Unknown | 45 (8)/130 (23)/308 (55)/59 (11)/19 (3) | 43.8/40.4/28.9/18.1/Unknown | <0.0001 |
| Kinugasa39 | 1997 | IV | 73 | 31.4 | NA |
NA, not applicable; OS, overall survival.
a
Disease‐specific survival.